wsm007 | February 25, 2026 | Based on Q3_FY25 (Sep-2025)
WAIT. Q4_FY25 reports tonight (Feb 25, 2026 after close) and it is the binary test of this thesis. I will not take a position before seeing those numbers. The Q3 data alone has enough yellow flags that buying here is speculation, not conviction.
Dec 2024 — I was "cautiously for ROOT." The thesis was PIF growth in the target market. Since then, the business has delivered mixed evidence. Let me rerun the tape with Q3_FY25 in hand.
| Q3_FY22 | Q3_FY23 | Q3_FY24 | Q3_FY25 | |
|---|---|---|---|---|
| Revenue ($M) | 73.7 | 115.3 | 305.7 | 387.8 |
| QoQ % | -8.3% | +54.1% | +5.7% | +1.3% |
| YoY % | — | — | +165.1% | +26.9% |
Q3 sequential growth has collapsed: 54% → 5.7% → 1.3%. At 1.3% QoQ, revenue is barely moving.
| Q4_FY24 | Q1_FY25 | Q2_FY25 | Q3_FY25 | |
|---|---|---|---|---|
| YoY % | 67.7% | 37.1% | 32.4% | 26.9% |
Three consecutive quarters of YoY deceleration. In my SaaS framework, two is the sell trigger. This is not SaaS — but a decelerating growth trend in any business is a yellow flag, not a green one.
Partial mitigation: Q2 was distorted by ROOT proactively lowering rates in Florida (double-digit rate cut). This compressed earned premium in Q2–Q3 due to the lag between written and earned. The true underlying GPW trajectory is less alarming.
| Q4_FY24 | Q1_FY25 | Q2_FY25 | Q3_FY25 | |
|---|---|---|---|---|
| GPW ($M) | 330.5 | 410.8 | 346.2 | 387.2 |
| QoQ % | — | +24.3% | -15.7% | +11.8% |
GPW recovered nicely in Q3 after the Florida-driven Q2 dip. Q1 GPW (410.8M)wasstrong—drivenbythenewpricingmodel.Q3GPW(387.2M) is growing 16.7% YoY vs Q3_FY24 ($331.7M). That's not exciting but it's stable.
| Q4_FY22 (Dec-22) | Q4_FY23 (Dec-23) | Q1_FY24 (Mar-24) | Q2_FY24 (Jun-24) | Q3_FY24 (Sep-24) | Q4_FY24 (Dec-24) | Q1_FY25 (Mar-25) | Q2_FY25 (Jun-25) | Q3_FY25 (Sep-25) | |
|---|---|---|---|---|---|---|---|---|---|
| PIF | 220,354 | 341,764 | 401,255 | 406,283 | 407,313 | 414,862 | 453,800 | 455,493 | 466,320 |
| QoQ % | — | — | +17.4% | +1.2% | +0.3% | +1.9% | +9.4% | +0.4% | +2.4% |
| YoY % | — | +55.1% | +17.4% | +18.9% | +19.1% | +21.4% | +13.1% | +12.1% | +14.5% |
| Premiums/Policy ($) | 1,220 | 1,423 | 1,482 | 1,522 | 1,558 | 1,584 | 1,614 | 1,616 | 1,581 |
| Q2_FY24 | Q3_FY24 | Q4_FY24 | Q1_FY25 | Q2_FY25 | Q3_FY25 | |
|---|---|---|---|---|---|---|
| PIF QoQ % | +1.2% | +0.3% | +1.9% | +9.4% | +0.4% | +2.4% |
The turnaround story in PIF is clear — from 220K at end of FY22 to 466K now, up 112%. But the recent QoQ trajectory matters: after the Q1_FY25 surge (+9.4%) driven by the new pricing model, growth stalled in Q2 (+0.4%, Florida) and only partially recovered in Q3 (+2.4%). The YoY reacceleration from 12.1% to 14.5% (Q2→Q3) is mildly encouraging — not a trend.
Premium per policy peaked at $1,616 in Q1_FY25 and dipped to $1,581 in Q3 — the Florida rate cut flowing through. This limits near-term revenue growth even if PIF recovers.
CEO stated October PIF "definitely accelerated" vs Q3 pace. That's the promise. Tonight we find out if it delivered.
CEO stated October PIF "definitely accelerated" vs Q3 pace. That's the promise. Tonight we find out if it delivered.
| Q3_FY24 | Q4_FY24 | Q1_FY25 | Q2_FY25 | Q3_FY25 | |
|---|---|---|---|---|---|
| Gross Margin % [GAAP] | 39.6% | 41.3% | 41.2% | 39.1% | 38.3% |
| Op Margin % [GAAP] | 11.3% | 10.7% | 6.8% | 7.1% | 0.1% |
| EBITDA Margin % | 13.6% | 13.2% | 9.1% | 9.8% | 8.7% |
| Net Margin % [GAAP] | 7.5% | 6.8% | 5.3% | 5.7% | -1.4% |
Op margin crashed from 11.3% to 0.1%. Net loss returned. At first glance: alarming.
The Carvana Warrant Distortion: $17M non-cash Carvana warrant expense in Q3, of which $15.5M was a cumulative catch-up from prior periods. This hit Other Insurance Expense, crushing management gross margin (21.0% vs 32.3% in Q3_FY24). Strip it out and the picture is materially better — implied adjusted op margin is ~4–5%.
But here's the thing: the warrant catch-up isn't fully one-time. As Carvana continues hitting milestones, warrant expense will continue. Management's "success of the partnership" framing is true, but it means this cost grows as the partnership scales. This is a recurring cost dressed as a one-off.
| Q3_FY24 | Q4_FY24 | Q1_FY25 | Q2_FY25 | Q3_FY25 | |
|---|---|---|---|---|---|
| Gross Loss Ratio % | 57.1% | 56.8% | 56.1% | 58.0% | 58.5% |
| Gross Expense Ratio % | 23.8% | 26.9% | 31.2% | 29.0% | 35.3% |
| Gross Combined Ratio % | 89.2% | 90.6% | 94.0% | 94.3% | 101.3% |
| Gross Accident Period Loss Ratio % | 55.5% | 61.4% | 56.2% | 60.3% | 59.5% |
The gross combined ratio went above 100% for the first time since the turnaround. That's the headline red flag. But dissecting it:
Accident period loss ratio: 59.5% — still within target. The underlying insurance economics are intact, for now.
ROOT's genuine competitive advantage:
The data supports the technology advantage. Loss ratios are running below target (60–65%) while growing faster than industry. The pricing algorithm is genuinely better.
Independent Agent Channel — The Growth Lever:
This is a real optionality. IA distribution is sticky and underpenetrated. If ROOT can continue growing IA appointments at 3x+ YoY while maintaining loss ratios, PIF accelerates structurally. This is the thesis.
The transcript tone is concerning. The mismatch between language and metrics is wide:
| What they said | What the data showed |
|---|---|
| "Position of strength" (repeated) | Op income: $0.3M |
| "Exceptional underwriting performance" | Combined ratio >100% |
| "We are just getting started" (repeated) | Revenue deceleration, 3 quarters |
| "Competition is about as hot as we've ever seen" | And we're still decelerating... |
| "Unmatched speed of innovation" | Unfalsifiable claim |
Root's management is high-energy, founder-led (Alex Timm), and genuinely believes in the mission. But I've seen this pattern before — founder conviction without accountability to the numbers. The analyst Q&A notably missed the warrant accounting gap and didn't push on the management gross margin collapse. That's a gap in coverage that benefits the company narrative.
The "not providing guidance" policy is a double-edged sword. It protects them from beat-and-lower, but also means there's no accountability mechanism beyond management's qualitative promises.
| Metric | Value |
|---|---|
| Market cap | $1.0B |
| Run-rate revenue (Q3 × 4) | $1.55B |
| Run-rate P/S | 0.65x |
| Run-rate adj EBITDA | $135M |
| EV/EBITDA (run-rate) | ~7x |
| YTD FCF (9M FY25) | ~$105M implied |
| TTM revenue | ~$1.45B |
| TTM P/S | 0.69x |
On valuation alone, ROOT is cheap. Progressive Insurance trades at ~2x P/S and is growing ~22% YoY. ROOT is growing faster (26.9%) with more technology upside, at 0.65x. The discount is warranted given execution risk and track record, but 3x cheaper than Progressive is a wide gap.
The valuation argument only works if:
At $1B market cap with 309Munencumberedcapitalonthebalancesheet, thedownsideiscapped.Adjustedmarketcapnetofexcesscapitalis 700M on a $1.55B run-rate revenue business. That's cheap.
Q4_FY25 results are releasing tonight. I need all four to maintain thesis-intact view:
| Tripwire | Threshold | Why |
|---|---|---|
| PIF | ≥490K (>5% QoQ) | CEO promised acceleration vs Q3's 2.4% |
| Revenue QoQ | ≥6% (back to Q4_FY24 pace) | Reverses deceleration trend |
| Gross combined ratio | <100% | Combined >100% in Q4 (excluding Carvana warrant) = structural concern |
| Gross accident period loss ratio | ≤64% | Q4 seasonality headwind acknowledged; should remain in target |
If Q4 misses on 2+ tripwires: Thesis is weakening. No position. Reassess in Q1_FY26. If Q4 clears all four: The Q3 trough was temporary. Conviction builds. Size appropriately.
| Q3_FY25 | |
|---|---|
| YoY Revenue Growth | 26.9% |
| Adj EBITDA Margin | 8.7% |
| Rule of 40 | 35.6% |
Below 40. Not exceptional. But for an insurance company at this revenue scale, not shameful either. FCF margin is stronger (~7.7% annualized) than EBITDA would suggest, which is a positive.
ROOT is an interesting special situation, not a core hypergrowth holding. The technology advantage is real. The IA channel optionality is real. The valuation is cheap. But:
I was cautiously interested in Dec 2024. I remain cautiously interested. But Q4_FY25 needs to deliver on the PIF acceleration promise before I'm a buyer. If tonight's print shows acceleration and combined ratios under control, this is genuinely interesting at $1B market cap with a real tech moat in a massive market.
If Q4 disappoints — run for the hills. The thesis was already fragile and one more quarter of deceleration closes the book.
→ WAIT for Q4 print. Re-evaluate tonight.
Not currently long ROOT.
-wsm